Sierra Oncology, Inc. EBITDA 2015-2022 | SRRA
Sierra Oncology, Inc. ebitda from 2015 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Sierra Oncology, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $-94 |
| 2020 | $-65 |
| 2019 | $-67 |
| 2018 | $-55 |
| 2017 | $-42 |
| 2016 | $-48 |
| 2015 | $-36 |
| 2014 | $-23 |
| 2013 | $-4 |
| Sierra Oncology, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-03-31 | $-28 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $-29 |
| 2021-06-30 | $-20 |
| 2021-03-31 | $-20 |
| 2020-12-31 | $-18 |
| 2020-09-30 | $-14 |
| 2020-06-30 | $-16 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-25 |
| 2019-09-30 | $-13 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-15 |
| 2018-09-30 | $-16 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-12 |
| 2017-12-31 | $-11 |
| 2017-09-30 | $-10 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-11 |
| 2016-12-31 | $-9 |
| 2016-09-30 | $-15 |
| 2016-06-30 | $-13 |
| 2016-03-31 | $-11 |
| 2015-12-31 | $-11 |
| 2015-09-30 | $-11 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $-3 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-14 |
| 2014-03-31 | $-2 |
